Profile
G.
Scott Walker is currently a Director at Pharmadelic Labs Corp., a Member of the International Cannabinoid Research Society, and a Member of the Cannabis Canada Association.
Previously, he worked as a Vice President-Corporate Development at Wildflower Brands, Inc.
G. Scott Walker active positions
| Companies | Position | Start |
|---|---|---|
Cannabis Canada Association
Cannabis Canada Association Pharmaceuticals: OtherHealth Technology Produces cannabis for medical purpose | Corporate Officer/Principal | - |
International Cannabinoid Research Society
International Cannabinoid Research Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit political and religious professional association to scientific research | Corporate Officer/Principal | - |
Pharmadelic Labs Corp.
Pharmadelic Labs Corp. Pharmaceuticals: OtherHealth Technology Improves engineering processes for the biosynthesis of compounds primarily psilocybin, the psychoactive component of magic mushrooms | Director/Board Member | - |
Former positions of G. Scott Walker
| Companies | Position | End |
|---|---|---|
| WILDFLOWER BRANDS INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Wildflower Brands, Inc.
Wildflower Brands, Inc. Pharmaceuticals: OtherHealth Technology Develops and wholesales CBD and cannabis wellness products | Health Technology |
International Cannabinoid Research Society
International Cannabinoid Research Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit political and religious professional association to scientific research | Commercial Services |
Cannabis Canada Association
Cannabis Canada Association Pharmaceuticals: OtherHealth Technology Produces cannabis for medical purpose | Health Technology |
Pharmadelic Labs Corp.
Pharmadelic Labs Corp. Pharmaceuticals: OtherHealth Technology Improves engineering processes for the biosynthesis of compounds primarily psilocybin, the psychoactive component of magic mushrooms | Health Technology |
- Stock Market
- Insiders
- G. Scott Walker
















